Can antiepileptic drugs unmask a susceptibility to psychiatric disorders?

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Psychiatric adverse events have been associated with rapid titration and high doses of most antiepileptic drugs (AEDs). However, several AEDs can cause such events at any dose. These agents include barbiturates, topiramate, levetiracetam and zonisamide. A search of the literature reveals that psychiatric adverse events associated with these AEDs seem not to occur at random. Rather, they are most likely to be reported by patients who have an inherent vulnerability to psychiatric disorders; that is, those with a personal or family history of psychiatric illness. In a recent study by Mula et al., patients who underwent rapid titration of topiramate had a fivefold increase in risk of depressive episodes. In patients with a history of depression, however, the risk increase was 23.3-fold. Thus, clinicians must ascertain a patient's personal and family psychiatric history before choosing an AED and planning the dose titration regimen.

Original languageEnglish (US)
Pages (from-to)132-133
Number of pages2
JournalNature Clinical Practice Neurology
Volume5
Issue number3
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Anticonvulsants
Psychiatry
zonisamide
etiracetam
Barbiturates
Depression
topiramate

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Can antiepileptic drugs unmask a susceptibility to psychiatric disorders? / Kanner, Andres M.

In: Nature Clinical Practice Neurology, Vol. 5, No. 3, 2009, p. 132-133.

Research output: Contribution to journalArticle

@article{12c5f3af35c648d1b7878647918e3f4e,
title = "Can antiepileptic drugs unmask a susceptibility to psychiatric disorders?",
abstract = "Psychiatric adverse events have been associated with rapid titration and high doses of most antiepileptic drugs (AEDs). However, several AEDs can cause such events at any dose. These agents include barbiturates, topiramate, levetiracetam and zonisamide. A search of the literature reveals that psychiatric adverse events associated with these AEDs seem not to occur at random. Rather, they are most likely to be reported by patients who have an inherent vulnerability to psychiatric disorders; that is, those with a personal or family history of psychiatric illness. In a recent study by Mula et al., patients who underwent rapid titration of topiramate had a fivefold increase in risk of depressive episodes. In patients with a history of depression, however, the risk increase was 23.3-fold. Thus, clinicians must ascertain a patient's personal and family psychiatric history before choosing an AED and planning the dose titration regimen.",
author = "Kanner, {Andres M}",
year = "2009",
doi = "10.1038/ncpneuro1051",
language = "English (US)",
volume = "5",
pages = "132--133",
journal = "Nature Reviews Neurology",
issn = "1759-4758",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Can antiepileptic drugs unmask a susceptibility to psychiatric disorders?

AU - Kanner, Andres M

PY - 2009

Y1 - 2009

N2 - Psychiatric adverse events have been associated with rapid titration and high doses of most antiepileptic drugs (AEDs). However, several AEDs can cause such events at any dose. These agents include barbiturates, topiramate, levetiracetam and zonisamide. A search of the literature reveals that psychiatric adverse events associated with these AEDs seem not to occur at random. Rather, they are most likely to be reported by patients who have an inherent vulnerability to psychiatric disorders; that is, those with a personal or family history of psychiatric illness. In a recent study by Mula et al., patients who underwent rapid titration of topiramate had a fivefold increase in risk of depressive episodes. In patients with a history of depression, however, the risk increase was 23.3-fold. Thus, clinicians must ascertain a patient's personal and family psychiatric history before choosing an AED and planning the dose titration regimen.

AB - Psychiatric adverse events have been associated with rapid titration and high doses of most antiepileptic drugs (AEDs). However, several AEDs can cause such events at any dose. These agents include barbiturates, topiramate, levetiracetam and zonisamide. A search of the literature reveals that psychiatric adverse events associated with these AEDs seem not to occur at random. Rather, they are most likely to be reported by patients who have an inherent vulnerability to psychiatric disorders; that is, those with a personal or family history of psychiatric illness. In a recent study by Mula et al., patients who underwent rapid titration of topiramate had a fivefold increase in risk of depressive episodes. In patients with a history of depression, however, the risk increase was 23.3-fold. Thus, clinicians must ascertain a patient's personal and family psychiatric history before choosing an AED and planning the dose titration regimen.

UR - http://www.scopus.com/inward/record.url?scp=62549149951&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549149951&partnerID=8YFLogxK

U2 - 10.1038/ncpneuro1051

DO - 10.1038/ncpneuro1051

M3 - Article

C2 - 19262587

AN - SCOPUS:62549149951

VL - 5

SP - 132

EP - 133

JO - Nature Reviews Neurology

JF - Nature Reviews Neurology

SN - 1759-4758

IS - 3

ER -